Information in confidence as set forth in Section 5.2. ARTICLE III DELIVERABLES AND COMPLETION 3.1 Deliverables. Subject to the remedies set forth in Section 3.4, Conformis shall furnish Stryker with the Deliverables as defined in the R&D Work Plan, and Stryker shall have the opportunity to analyze and test each Deliverable for the purposes of determining Acceptance as set forth in the R&D Work Plan. Each Deliverable shall be deemed to be completed once such Deliverable has been Accepted (as defined below). 3.2 Free from Infringement. Without the consent of Stryker, Conformis shall not introduce any structure or methodology in the Deliverables (including a Deliverable within a Product or a Stryker Product) that (1) raise a colorable argument of patent infringement in the manufacture, use, sale, offer for sale or importation of the Deliverable as such Deliverable 8 Source: CONFORMIS INC, 10-Q, 11/1/2019 is intended to be exploited under the Other Agreements, (2) misappropriate any Confidential Information of any Third Party, or (3) otherwise violate any Intellectual Property rights of any Third Party. For clarity, disclosure of a matter on the Disclosure Schedules to the Asset Purchase Agreement shall not be deemed consent by Stryker under this Section 3.2. 3.3 Completion. After a Deliverable has been furnished to Stryker, Stryker (or its Agent designee) will be entitled to analyze and test the Deliverable to determine if it operates in accordance with and otherwise conforms to the applicable Acceptance Criteria set forth in R&D Work Plan. Conformis shall provide such assistance as Stryker may reasonably request in such determination. Stryker shall have [**] ("Acceptance Notification Period") following the date the Deliverable is received by Stryker to Accept or reject the Deliverable as described in Section 3.4. 3.4 Acceptance or Rejection. Respecting any Deliverable for Milestone #1 or Milestone #2, as set